Qube Research & Technologies LTD Glaukos Corp Transaction History
Qube Research & Technologies LTD
- $72.9 Billion
- Q4 2024
A detailed history of Qube Research & Technologies LTD transactions in Glaukos Corp stock. As of the latest transaction made, Qube Research & Technologies LTD holds 25,174 shares of GKOS stock, worth $2.27 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
25,174
Previous 15,064
67.11%
Holding current value
$2.27 Million
Previous $1.96 Million
92.35%
% of portfolio
0.01%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding GKOS
# of Institutions
350Shares Held
48MCall Options Held
282KPut Options Held
401K-
Black Rock Inc. New York, NY8.04MShares$725 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.97MShares$539 Million0.02% of portfolio
-
State Street Corp Boston, MA2.06MShares$186 Million0.01% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN1.93MShares$174 Million0.08% of portfolio
-
Invesco Ltd. Atlanta, GA1.46MShares$132 Million0.04% of portfolio
About GLAUKOS Corp
- Ticker GKOS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,596,900
- Market Cap $4.3B
- Description
- Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...